Genes | Plasma detection | CTC detection |
---|
CCL5
|
A,B,C
|
B
|
CLU
|
A,B,C
|
B
|
GPX1 |
A,B,C
|
B
|
AKT3 |
A,B,C
| Â |
ARHGDIB |
A,B,C
| Â |
SPARC
|
A,B,C
| Â |
SRGN
|
A,B,C
| Â |
TNXB |
A,B,C
| Â |
THBS1
|
B,C
|
B
|
BAI1 |
B,C
| Â |
CLDN1 |
B,C
| Â |
EGF
|
B,C
| Â |
FHL1 |
B,C
| Â |
PDK1 |
B,C
| Â |
PLEKHO1 |
B,C
| Â |
RBL1 |
B,C
| Â |
RBX1 |
B,C
| Â |
TGFB1
|
B,C
| Â |
GIMAP4 |
B
|
B
|
ITGB3
|
C
|
C
|
PECAM1 |
C
|
B
|
LRG1 | Â |
B,C
|
PKN1 | Â |
B,C
|
- Only genes satisfying at least two cutoff criteria are shown. A, genes consistently showing higher expression based on plasma and CTC analyses; B and C, first and second tier of rare cancer-specific events. See Material and Methods for details. Bold face, genes forming a tight (confidence score > 0.9) cluster by interaction analysis using String database